Cargando…
Binding between ROCK1 and DCTN2 triggers diabetes-associated centrosome amplification in colon cancer cells
Type 2 diabetes increases the risk various types of cancer and is associated with a poor prognosis therein. There is also evidence that the disease is associated with cancer metastasis. Centrosome amplification can initiate tumorigenesis with metastasis in vivo and increase the invasiveness of cance...
Autores principales: | Li, Yuan Fei, Shi, Lin Jie, Wang, Pu, Wang, Jia Wen, Shi, Guang Yi, Lee, Shao Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185503/ https://www.ncbi.nlm.nih.gov/pubmed/34080666 http://dx.doi.org/10.3892/or.2021.8102 |
Ejemplares similares
-
Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma
por: Wang, Shijun, et al.
Publicado: (2018) -
PCNA and JNK1‐Stat3 pathways respectively promotes and inhibits diabetes‐associated centrosome amplification by targeting at the ROCK1/14‐3‐3σ complex in human colon cancer HCT116 cells
por: Lu, Yu Cheng, et al.
Publicado: (2018) -
Loss of KLF14 triggers centrosome amplification and tumorigenesis
por: Fan, Guangjian, et al.
Publicado: (2015) -
DCTN1 mutations in Perry syndrome
por: Farrer, Matthew J., et al.
Publicado: (2009) -
DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
por: Deshimaru, Manami, et al.
Publicado: (2021)